Radiosensitizer
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Pirfenidone as a Radiosensitizer in the Treatment of Head and Neck Squamous Cell Carcinoma (NCT06142318) | Nanfang Hospital, Southern Medical University | 2023-11-15 |
Track Radiosensitizer automatically
Every clearance here is in the API, with alerts when new ones post.